In vivo detection of ultrasonically induced cavitation by a fibre-optic technique.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 7863570)

Published in Ultrasound Med Biol on January 01, 1994

Authors

P Huber1, J Debus, P Peschke, E W Hahn, W J Lorenz

Author Affiliations

1: Department of Biophysics and Medical Radiation Physics, German Cancer Research Center, Heidelberg.

Articles by these authors

Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med (1997) 2.42

Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr (1991) 2.34

Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol (2001) 2.28

Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology (1994) 2.05

PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med (2001) 2.01

A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res (2001) 1.66

Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med (1995) 1.65

Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol (1998) 1.49

MR imaging of fat-containing tissues: valuation of two quantitative imaging techniques in comparison with localized proton spectroscopy. Magn Reson Imaging (1993) 1.41

Fast and precise T1 imaging using a TOMROP sequence. Magn Reson Imaging (1990) 1.41

Medical gamma processing facility in Riyadh, Saudi Arabia, and radiation applications. Int J Appl Radiat Isot (1985) 1.37

Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology (2006) 1.36

Influence of shock wave pressure amplitude and pulse repetition frequency on the lifespan, size and number of transient cavities in the field of an electromagnetic lithotripter. Phys Med Biol (1998) 1.32

Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam? Radiother Oncol (2001) 1.30

Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol (2001) 1.29

Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int J Radiat Oncol Biol Phys (2000) 1.28

Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor. Int J Radiat Oncol Biol Phys (2001) 1.26

A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol (1999) 1.24

An in situ method for estimating cell survival in a solid tumor. Cancer Res (1978) 1.23

Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer (2008) 1.23

Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys (2000) 1.22

Spin-lattice relaxation time measurement by means of a TurboFLASH technique. Magn Reson Med (1993) 1.19

Recovery from aspermia induced by low-dose radiation in seminoma patients. Cancer (1982) 1.17

Glass-ceramic-mediated, magnetic-field-induced localized hyperthermia: response of a murine mammary carcinoma. Radiat Res (1983) 1.16

4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer. Int J Radiat Biol (1999) 1.15

Selection of beam angles for radiotherapy of skull base tumours using charged particles. Phys Med Biol (2000) 1.13

Adjuvant treatment of brain metastases. Semin Surg Oncol (2001) 1.12

FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol (1994) 1.11

Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. J Neurooncol (2005) 1.11

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]. BMC Cancer (2005) 1.10

Non-invasive determination of tumor oxygen tension and local variation with growth. Int J Radiat Oncol Biol Phys (1994) 1.09

Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging (1999) 1.09

Control of cavitation activity by different shockwave pulsing regimes. Phys Med Biol (1999) 1.07

The Heidelberg Ion Therapy Center. Radiother Oncol (2004) 1.06

Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys (2001) 1.05

Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients. Strahlenther Onkol (2013) 1.05

Fast fluid-attenuated inversion-recovery (FLAIR) MRI in the assessment of intraaxial brain tumors. J Magn Reson Imaging (1998) 1.05

Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology (2002) 1.04

Diffusion tensor imaging screening of radiation-induced changes in the white matter after prophylactic cranial irradiation of patients with small cell lung cancer: first results of a prospective study. AJNR Am J Neuroradiol (2007) 1.04

Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. Radiology (2003) 1.04

Diagnostic accuracy of computerized B-scan texture analysis and conventional ultrasonography in diffuse parenchymal and malignant liver disease. J Clin Ultrasound (1985) 1.04

Monte Carlo simulations to support start-up and treatment planning of scanned proton and carbon ion therapy at a synchrotron-based facility. Phys Med Biol (2012) 1.03

Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys (2001) 1.02

Lectin--peroxidase conjugates in histopathology of gastrointestinal mucosa. Virchows Arch A Pathol Anat Histopathol (1983) 1.01

Three-dimensional accuracy and interfractional reproducibility of patient fixation and positioning using a stereotactic head mask system. Int J Radiat Oncol Biol Phys (2001) 1.01

Correction of spatial distortion in magnetic resonance angiography for radiosurgical treatment planning of cerebral arteriovenous malformations. Magn Reson Imaging (1992) 1.01

Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. Int J Cancer (2001) 1.01

Cerebral radiation surgery using moving field irradiation at a linear accelerator facility. Int J Radiat Oncol Biol Phys (1985) 1.00

Clinical and biological studies of localized hyperthermia. Cancer Res (1979) 1.00

Noninvasive patient fixation for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.00

Influence of intra-fractional breathing movement in step-and-shoot IMRT. Phys Med Biol (2004) 1.00

Combination hyperthermia and radiation therapy for malignant melanoma. Cancer (1982) 1.00

High-resolution MR venography of cerebral arteriovenous malformations. Magn Reson Imaging (1999) 0.99

Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit. Breast (2012) 0.99

Heavy ion therapy: status and perspectives. Technol Cancer Res Treat (2003) 0.99

Multimodality imaging of hypoxia in preclinical settings. Q J Nucl Med Mol Imaging (2010) 0.98

Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med (2001) 0.98

Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Ther (2003) 0.97

Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys (2000) 0.97

Cerebral arteriovenous malformations: improved nidus demarcation by means of dynamic tagging MR-angiography. Magn Reson Imaging (1996) 0.96

Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation. Strahlenther Onkol (2012) 0.96

Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res (1988) 0.96

A new method of quantitative cavitation assessment in the field of a lithotripter. Ultrasound Med Biol (1996) 0.95

Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283]. BMC Cancer (2005) 0.95

Multiexponential proton spin-spin relaxation in MR imaging of human brain tumors. J Comput Assist Tomogr (1989) 0.95

Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys (2000) 0.95

Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys (2001) 0.94

Regional tumor oximetry: 19F NMR spectroscopy of hexafluorobenzene. Int J Radiat Oncol Biol Phys (1998) 0.94

Cerebral gliomas and metastases: assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology (1999) 0.94

Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comparison with a 3D-treated patient cohort. Strahlenther Onkol (2013) 0.94

Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound--initial results. Eur Radiol (2005) 0.93

Human tumor xenografts as model for drug testing. Cancer Metastasis Rev (1988) 0.93

Isolated tumor growth in a surgically formed skin pedicle in the rat: a new tumor model for NMR studies. Magn Reson Imaging (1993) 0.92

Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment. Radiat Oncol (2006) 0.92

Intensity-modulated radiotherapy - technology and clinical applications. Onkologie (2002) 0.91

Regional tumor oxygen tension: fluorine echo planar imaging of hexafluorobenzene reveals heterogeneity of dynamics. Int J Radiat Oncol Biol Phys (1998) 0.91

Review of clinical experience with ion beam radiotherapy. Br J Radiol (2011) 0.91

Regional tumor oxygenation and measurement of dynamic changes. Radiat Res (1999) 0.90

Differential sensitivity of three sublines of the rat Dunning prostate tumor system R3327 to radiation and/or local tumor hyperthermia. Radiat Res (1998) 0.90

The radiosensitization of hypoxic tumor cells by hyperthermia. Radiology (1975) 0.90

Delayed vascular injury after single high-dose irradiation in the rat brain: histologic immunohistochemical, and angiographic studies. Radiology (1999) 0.90

[Database supported electronic retrospective analyses in radiation oncology: establishing a workflow using the example of pancreatic cancer]. Strahlenther Onkol (2012) 0.90

[High resolution MR-venography of cerebral arteriovenous malformations]. Radiologe (2001) 0.90

Treatment of the Dunning prostate rat tumor R3327-AT1 with pulsed high energy ultrasound shock waves (PHEUS): growth delay and histomorphologic changes. J Urol (1991) 0.90

Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol (1996) 0.90

Kilovoltage CT using a linac-CT scanner combination. Br J Radiol (2006) 0.90

Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imaging (1998) 0.89